Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: A multicentre, open-label, 52-week phase III trial
Journal of Neurology, Neurosurgery & Psychiatry | Aug 15, 2017
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Clinical Pharmacology: Advances and Applications | Aug 15, 2017
Association between mild cognitive impairment and trajectory-based spatial parameters during Timed Up and Go test using a laser range sensor
Journal of NeuroEngineering and Rehabilitation | Aug 14, 2017